N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine

C113H100N38O5S — CID 158421413

IUPACN-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine
SMILESCn1cc(-c2cnc3c(NC4CCOCC4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc(Oc5ccccc5)cc4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc(S(C)(=O)=O)cc4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5[nH]ccc5c4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5ncccc5c4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4cccc(Oc5ccccc5)c4)nccn23)cn1
InChIInChI=1S/2C22H18N6O.C19H15N7.C18H15N7.C17H16N6O2S.C15H18N6O/c1-27-15-16(13-25-27)20-14-24-22-21(23-10-11-28(20)22)26-17-6-5-9-19(12-17)29-18-7-3-2-4-8-18;1-27-15-16(13-25-27)20-14-24-22-21(23-11-12-28(20)22)26-17-7-9-19(10-8-17)29-18-5-3-2-4-6-18;1-25-12-14(10-23-25)17-11-22-19-18(21-7-8-26(17)19)24-15-4-5-16-13(9-15)3-2-6-20-16;1-24-11-13(9-22-24)16-10-21-18-17(20-6-7-25(16)18)23-14-2-3-15-12(8-14)4-5-19-15;1-22-11-12(9-20-22)15-10-19-17-16(18-7-8-23(15)17)21-13-3-5-14(6-4-13)26(2,24)25;1-20-10-11(8-18-20)13-9-17-15-14(16-4-5-21(13)15)19-12-2-6-22-7-3-12/h2*2-15H,1H3,(H,23,26);2-12H,1H3,(H,21,24);2-11,19H,1H3,(H,20,23);3-11H,1-2H3,(H,18,21);4-5,8-10,12H,2-3,6-7H2,1H3,(H,16,19)
InChIKeyHANNPDAJQOBCLR-UHFFFAOYSA-N
MW2102.37 g/mol
LogP20.11
Rot. Bonds23

About N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine

N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine (PubChem CID 158421413) has the molecular formula C113H100N38O5S and a molecular weight of 2102.37 g/mol. Its IUPAC name is N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine.

Molecular Properties

Compound NameN-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine
PubChem CID158421413
Molecular FormulaC113H100N38O5S
Molecular Weight2102.37 g/mol
Exact Mass2100.85
IUPAC NameN-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine
SMILESCn1cc(-c2cnc3c(NC4CCOCC4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc(Oc5ccccc5)cc4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc(S(C)(=O)=O)cc4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5[nH]ccc5c4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5ncccc5c4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4cccc(Oc5ccccc5)c4)nccn23)cn1
InChIInChI=1S/2C22H18N6O.C19H15N7.C18H15N7.C17H16N6O2S.C15H18N6O/c1-27-15-16(13-25-27)20-14-24-22-21(23-10-11-28(20)22)26-17-6-5-9-19(12-17)29-18-7-3-2-4-8-18;1-27-15-16(13-25-27)20-14-24-22-21(23-11-12-28(20)22)26-17-7-9-19(10-8-17)29-18-5-3-2-4-6-18;1-25-12-14(10-23-25)17-11-22-19-18(21-7-8-26(17)19)24-15-4-5-16-13(9-15)3-2-6-20-16;1-24-11-13(9-22-24)16-10-21-18-17(20-6-7-25(16)18)23-14-2-3-15-12(8-14)4-5-19-15;1-22-11-12(9-20-22)15-10-19-17-16(18-7-8-23(15)17)21-13-3-5-14(6-4-13)26(2,24)25;1-20-10-11(8-18-20)13-9-17-15-14(16-4-5-21(13)15)19-12-2-6-22-7-3-12/h2*2-15H,1H3,(H,23,26);2-12H,1H3,(H,21,24);2-11,19H,1H3,(H,20,23);3-11H,1-2H3,(H,18,21);4-5,8-10,12H,2-3,6-7H2,1H3,(H,16,19)
InChIKeyHANNPDAJQOBCLR-UHFFFAOYSA-N
XLogP20.11
TPSA450.75 Ų
H-Bond Donors7
H-Bond Acceptors42
Rotatable Bonds23
Heavy Atoms157
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002102.37
LogP ≤ 520.11
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1042

Analyze N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine?
The IUPAC name of N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine (CID 158421413) is N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine.
What is the SMILES notation for N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine?
The canonical SMILES for N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine is Cn1cc(-c2cnc3c(NC4CCOCC4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc(Oc5ccccc5)cc4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc(S(C)(=O)=O)cc4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5[nH]ccc5c4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5ncccc5c4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4cccc(Oc5ccccc5)c4)nccn23)cn1.
What is the InChIKey of N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine?
The InChIKey is HANNPDAJQOBCLR-UHFFFAOYSA-N. The full InChI is InChI=1S/2C22H18N6O.C19H15N7.C18H15N7.C17H16N6O2S.C15H18N6O/c1-27-15-16(13-25-27)20-14-24-22-21(23-10-11-28(20)22)26-17-6-5-9-19(12-17)29-18-7-3-2-4-8-18;1-27-15-16(13-25-27)20-14-24-22-21(23-11-12-28(20)22)26-17-7-9-19(10-8-17)29-18-5-3-2-4-6-18;1-25-12-14(10-23-25)17-11-22-19-18(21-7-8-26(17)19)24-15-4-5-16-13(9-15)3-2-6-20-16;1-24-11-13(9-22-24)16-10-21-18-17(20-6-7-25(16)18)23-14-2-3-15-12(8-14)4-5-19-15;1-22-11-12(9-20-22)15-10-19-17-16(18-7-8-23(15)17)21-13-3-5-14(6-4-13)26(2,24)25;1-20-10-11(8-18-20)13-9-17-15-14(16-4-5-21(13)15)19-12-2-6-22-7-3-12/h2*2-15H,1H3,(H,23,26);2-12H,1H3,(H,21,24);2-11,19H,1H3,(H,20,23);3-11H,1-2H3,(H,18,21);4-5,8-10,12H,2-3,6-7H2,1H3,(H,16,19).
What are the key properties of N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine?
N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine has a molecular weight of 2102.37 g/mol, XLogP of 20.11, 23 rotatable bonds, 7 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1H-indol-5-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]quinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-methylsulfonylphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(3-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-N-(4-phenoxyphenyl)imidazo[1,2-a]pyrazin-8-amine is sourced from PubChem (CID 158421413), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).